Haemostatic Changes in Five Patients Infected with Ebola Virus

Knowledge on haemostatic changes in humans infected with Ebola virus is limited due to safety concerns and access to patient samples. Ethical approval was obtained to collect plasma samples from patients in Sierra Leone infected with Ebola virus over time and samples were analysed for clotting time, fibrinogen, and D-dimer levels. Plasma from healthy volunteers was also collected by two methods to determine effect of centrifugation on test results as blood collected in Sierra Leone was not centrifuged. Collecting plasma without centrifugation only affected D-dimer values. Patients with Ebola virus disease had higher PT and APTT and D-dimer values than healthy humans with plasma collected in the same manner. Fibrinogen levels in patients with Ebola virus disease were normal or lower than values measured in healthy people. Clotting times and D-dimer levels were elevated during infection with Ebola virus but return to normal over time in patients that survived and therefore could be considered prognostic. Informative data can be obtained from plasma collected without centrifugation which could improve patient monitoring in hazardous environments.

[1]  G. Ippolito,et al.  Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Strong,et al.  Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness , 2017, Scientific Reports.

[3]  H. ten Cate,et al.  Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories , 2016, Thrombosis Journal.

[4]  Dennis Williams,et al.  Disseminated Intravascular Coagulation. , 2016, American journal of clinical pathology.

[5]  L. Nyakarahuka,et al.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence , 2016, BMC Infectious Diseases.

[6]  Christos T. Nakas,et al.  Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome , 2016, Metabolomics.

[7]  Timothy D. Flietstra,et al.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Bhagani,et al.  Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Brault,et al.  Prognostic Indicators for Ebola Patient Survival , 2016, Emerging infectious diseases.

[10]  T. Fletcher,et al.  Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[11]  F. Salguero,et al.  Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. , 2015, The Journal of infectious diseases.

[12]  Rachel S. G. Sealfon,et al.  Clinical illness and outcomes in patients with Ebola in Sierra Leone. , 2014, The New England journal of medicine.

[13]  Ying Zhao,et al.  Effects of storage time and temperature on coagulation tests and factors in fresh plasma , 2014, Scientific Reports.

[14]  M. Lackemeyer,et al.  Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. , 2011, Microbes and infection.

[15]  B. Lämmle,et al.  Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: only a part of the story. Reply to E. J. Favaloro , 2008, Thrombosis and Haemostasis.

[16]  P. Jahrling,et al.  Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. , 2007, The Journal of infectious diseases.

[17]  A. Sanchez,et al.  Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. , 2007, The Journal of infectious diseases.

[18]  A. Kratz,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. , 2004, The New England journal of medicine.

[19]  P. Jahrling,et al.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys , 2003, The Lancet.

[20]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[21]  D. Cook,et al.  Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene. , 2001, American journal of epidemiology.

[22]  H. Cohen,et al.  Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  J. P. Chen,et al.  Hemorrhagic fever virus-induced changes in hemostasis and vascular biology , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[24]  R. Swanepoel,et al.  Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects , 2000, Critical care medicine.

[25]  E. Ryabchikova,et al.  An analysis of features of pathogenesis in two animal models of Ebola virus infection. , 1999, The Journal of infectious diseases.

[26]  Sinroku Otatume,et al.  Ebola haemorrhagic fever in Zaire , 1996 .

[27]  A. Barrett,et al.  HAEMATOLOGICAL AND BIOCHEMICAL MONITORING OF EBOLA INFECTION IN RHESUS MONKEYS: IMPLICATIONS FOR PATIENT MANAGEMENT , 1983, The Lancet.

[28]  J. F. Wallace,et al.  CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. , 1965, The New England journal of medicine.

[29]  Tom Fletcher,et al.  Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. , 2015, The New England journal of medicine.

[30]  Ebola haemorrhagic fever in Zaire, 1976. , 1978, Bulletin of the World Health Organization.